2_SAGE_Appendicies_Background_final

More documents

Recommendations

Info

ANNEX 1: List of countries by Indicator 1Member State Assessment Type Top 3 Reason Assessment/OpinionBasedAndorra No EvidenceAzerbaijanCyprusGeorgiaHungaryLatviaLithuaniaNorwaySpainSwedenSwitzerlandTajikistanUzbekistanSloveniaNoNoNoNoNoNoNoNoNoNoNoNoNoMontenegro No 1. Activities of antivaccinationindividualsand groups2. Misinformation throughinternet3. Sensational approach ofmedia who give a lot ofspace to everyone whohas something to sayagainst officialapproach toimmunizationFinland No 1. Fear of adverse events2. Anthroposophicphilosophy3. Religious points of viewIceland No 1. Fear of adverse effects2. Naturalistic viewsMalta No 1. Fear of adversereactions2. Anti-vaccine internetsites3. Lack of interestOpinionOpinionOpinionOpinion47
Czech Republic No 1. The fear of side effectsof vaccination2. The lack of knowledgeof the course of realdiseases.3. Perception ofpharmaceuticalcompanies like those,whose main interest isto earn money.Turkey No But, there are lessonslearnt from the public andthe public healthdirectorates that day by dayvaccine refusal and groupsagainst vaccines1. The side of the vaccineslearnt from somewebsites by the public.2. Some religious reasons3. The thought of havingso many vaccines(antigens) in thevaccination schedule, somuch administrationswould be harmful childhealthBelarus No 1. наличие большогоколичества негативнойинформации поиммунизации в СМИ[the large number ofnegative information onimmunization in themedia]2. недоверие кбезопасностиприменяемых вакцин[distrust of securityused vaccines]3. отсутствиевакциноуправляемыхинфекций [lack ofvaccine-preventablediseases]Portugal Yes http://repositorium.sdum.uminho.pt/bitstream/1822/11888/1/Raz%c3%b5es%20de%20Sa%c3%bade_Cunha%2cDurand.pdfRomania Yes 1. No presention on call2. Refusal3. MedicalcontraindicationSlovakia Yes 1. Fear of adversereactions2. Distrust3. UselessnessOpinionOpinionOpinionEvidenceEvidence48
Page 1: APPENDICES TO THEREPORT OF THE SAGE
Page 4 and 5: vaccine hesitancy in low income cou
Page 6 and 7: INDIVIDUAL andGROUPINFLUENCESInflue
Page 8 and 9: Another model reviewed by the Worki
Page 10 and 11: Appendix for Section 4Appendix A4.1
Page 13 and 14: epresented mostly low and middle in
Page 15 and 16: was more hesitant than the younger
Page 17 and 18: a variable or to a lack of understa
Page 19 and 20: References[1] World Health Organiza
Page 21 and 22: Country FVaccine hesitancy is not a
Page 23 and 24: Figure 1. IMs’ opinions regarding
Page 25 and 26: DefinitionVaccination confidence is
Page 27 and 28: Of all participating countries, 19%
Page 29 and 30: Countries from all 3 regions provid
Page 31 and 32: Table 5: Income level of countries
Page 33 and 34: variety of determinants of vaccine
Page 35 and 36: Uruguay no no responseVenezuela no
Page 37 and 38: RussianFederationyesQuestioning dur
Page 39 and 40: Question 2:Was this % measured or e
Page 41 and 42: Of those countries which submitted
Page 43 and 44: Indicator 2:Indicator 2 was modifie
Page 45 and 46: Table 4. Top three reasons for vacc
Page 47: The overall response rate to both i
Page 51 and 52: Kyrgyzstan Yes В 2013 году в
Page 53 and 54: Table A5.3 .1: Survey questions to
Page 55 and 56: Table A5.3.1: Survey questions to a
Page 57 and 58: Table A5.3.2: Survey questions to a
Page 59 and 60: Appendix A5.4 WHO EUR Tailoring Imm
Page 61 and 62: Objective 2 - Characteristics of ev
Page 63 and 64: Most interventions targeted parents
Page 65 and 66: Table 2. PICO questions proposed by
Page 67 and 68: Dialogue-based interventionsEleven
Page 69 and 70: The impact of information-based tra
Page 71 and 72: Conclusions and implicationsLiterat
Page 73 and 74: Appendix A6A.2 Strategies to addres
Page 75 and 76: change in attitudes).- Most studies
Page 77 and 78: Strategies to address vaccine hesit
Page 79 and 80: Table 1.Summary of published litera
Page 81 and 82: Title/ First author/year of publica
Page 91 and 92: References1. Williams, S.E., What a
Page 93 and 94: Appendix A6C.1 Vaccine Hesitancy La
Page 95 and 96: ii. Google (Hong Kong)• Used the
Page 97 and 98: Categories Key Actors Areas ofWork/
Page 99 and 100:
Categories Key Actors Areas ofWork/
Page 101 and 102:
Categories Key Actors Areas ofActio
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
This landscape analysis, along with
Page 109 and 110:
References for Vaccine Hesitancy La
Page 111:
67 Robert Wood Johnson Foundation.
show all

2_SAGE_Appendicies_Background_final

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?